Efficacy vs Placebo as Initial Combination Therapy With Pioglitazone

Clinical trial NCT00641043 · COMPLETED

Trial details

NCT number: NCT00641043
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2008-03-01
Primary completion: 2009-06-01
Enrollment: 389

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.